What this means
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- 64 studies, mostly cells, animals, and small human trials
- Kind of research
- A study
The science
- Original title
- A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.
- Authors
- Najafi N, Maatouk H, Vardanyan KG et al.
- Journal
- Archives of internal medicine research
- Published
- Sep 25, 2026
- Study type
- Study
- PMID
- 42787770 ↗
Abstract
GHK-Cu, the copper-bound form of the human tripeptide glycyl-L-histidyl-L-lysine has accumulated more than four decades of pre-clinical evidence for tissue regeneration, anti-inflammatory action, antioxidant capacity, and broad gene-expression remodeling. Yet despite this volume, the clinical literature in humans remains thin and fragmented: most randomized trials are small, conducted on facial cosmetic creams, and rarely paired with delivery technologies capable of reliably crossing the stratum corneum. The microneedle-mediated delivery route which has been shown in vitro and in porcine ex vivo models to dramatically enhance GHK-Cu skin uptake has yet to be evaluated in a single registered, adequately powered human randomized controlled trial published in the peer-reviewed literature. This systematic review synthesizes the body of GHK-Cu literature published between 2005 and 2026, mapped against the PRISMA framework. Searches across PubMed, Elsevier ScienceDirect, and the Cochrane CENTRAL Registry yielded 1,247 records; after deduplication and screening, 64 records were retained for qualitative synthesis. Studies were stratified by study model (in vitro, ex vivo, in vivo rodent, in vivo non-rodent, and human) so that comparator therapies could be matched on equivalent footing. A critical discussion is provided on the physiology and underlying mechanistic foundation of GHK-Cu activity, including its role as an endogenous matricryptin released from collagen Iα2 and SPARC, copper's essential cofactor function for the lysyl oxidase family of cross-linking enzymes, decorin and glycosaminoglycan organization of newly deposited matrix, TGF-β3-mediated reduction of fibrosis, and ferritin-iron-modulated antioxidant defense. A dedicated surgical wound healing section addresses the evidence base for GHK-Cu in CO2 laser resurfacing, irradiated tissue and post-radiation reconstruction, Mohs micrographic surgery wounds, skin grafts, and hair transplant sites. The synthesis confirms a deep, mechanistically coherent body of preclinical evidence and reveals a defined evidence gap: well-designed human trials of GHK-Cu delivered via microneedle or microneedle-adjacent platforms (dissolvable patches, hollow microneedle arrays, dermaroller-assisted serums) are needed to translate the strong cellular and animal data into validated clinical practice. Specific recommendations for trial design stratified by indication (photoaging, androgenetic alopecia, atrophic acne scarring, chronic wound healing, post-Mohs cosmetic outcomes, post-radiation surgical reconstruction) are provided.
Najafi N, Maatouk H, Vardanyan KG et al. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Archives of internal medicine research. 2026. doi:10.26502/aimr.0255. PMID: 42787770. https://pubmed.ncbi.nlm.nih.gov/42787770/
Related research
Home exercise may change muscle in people with kidney disease
A small trial found changes in muscle blood vessels and fewer fibrosis-linked cells after 12 weeks of home exercise. Only 25 people took part, so this does not prove the exercise caused lasting muscle benefits.
Protein NEDD4 may protect disc cells from aging and cell death in a lab test
Researchers grew disc cells in a dish with an inflammation signal. Boosting NEDD4 eased aging and cell death, and it broke down another protein called PTEN. More tests in living animals and more checks are still needed.
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
A skin mix with GHK-Cu may help wrinkles and skin barrier in tests
Researchers tested a mix of a ferment extract and a copper peptide for skin aging. The results suggest it may help, but these early tests do not prove it works for everyone.
Review of a copper peptide used in skin treatments
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
Review finds GHK-Cu promising in lab and animal studies but unproven in people
Authors reviewed studies of GHK-Cu, a copper-peptide, across labs, animals, small human tests, and drug-delivery work. They say it is not yet a proven treatment for people.
See all research on GHK-Cu (copper peptide) →